|NASDAQ: BCPC||Basic Materials / Chemicals / USA|
|126.48||+1.58||+1.27%||Vol 106.25K||1Y Perf -8.63%|
|Mar 31st, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||163.50||Analyst Rating||Strong Buy 1.00|
|Potential %||29.27||Finscreener Ranking||★★★ 49.92|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||★★+ 49.50|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||★★★★+ 60.58|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||★★ 39.70|
|Price Range Ratio 52W %||48.42||Earnings Rating||Sell|
|Market Cap||4.07B||Earnings Date||5th May 2023|
Today's Price Range
5 Year PE Ratio Range
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||5th May 2023|
|Estimated EPS Next Report||0.78|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||73.94K|
|Avg. Monthly Volume||101.08K|
|Avg. Quarterly Volume||101.10K|
Balchem Corporation (NASDAQ: BCPC) stock closed at 126.48 per share at the end of the most recent trading day (a 1.27% change compared to the prior day closing price) with a volume of 106.25K shares and market capitalization of 4.07B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Chemicals industry, Basic Materials sector and employs 1342 people. Balchem Corporation CEO is Theodore L. Harris.
The one-year performance of Balchem Corporation stock is -8.63%, while year-to-date (YTD) performance is 3.58%. BCPC stock has a five-year performance of 54.72%. Its 52-week range is between 110.1456 and 143.88, which gives BCPC stock a 52-week price range ratio of 48.42%
Balchem Corporation currently has a PE ratio of 36.30, a price-to-book (PB) ratio of 4.36, a price-to-sale (PS) ratio of 5.66, a price to cashflow ratio of 27.90, a PEG ratio of 2.32, a ROA of 8.28%, a ROC of 9.52% and a ROE of 13.21%. The company’s profit margin is 11.83%, its EBITDA margin is 21.30%, and its revenue ttm is $709.83 Million , which makes it $22.09 revenue per share.
Of the last four earnings reports from Balchem Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.78 for the next earnings report. Balchem Corporation’s next earnings report date is 05th May 2023.
The consensus rating of Wall Street analysts for Balchem Corporation is Strong Buy (1), with a target price of $163.5, which is +29.27% compared to the current price. The earnings rating for Balchem Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Balchem Corporation has a dividend yield of 0.57% with a dividend per share of $0.71 and a payout ratio of 21.00%.
Balchem Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.97, ATR14 : 3.65, CCI20 : -62.40, Chaikin Money Flow : -0.06, MACD : -1.59, Money Flow Index : 39.60, ROC : -0.32, RSI : 48.47, STOCH (14,3) : 69.37, STOCH RSI : 1.00, UO : 62.10, Williams %R : -30.63), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Balchem Corporation in the last 12-months were: David B. Fischer (Sold 3 000 shares of value $381 021 ), Job van Gunsteren (Option Excercise at a value of $728 080), Job van Gunsteren (Sold 17 202 shares of value $2 182 999 )
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Strong Buy||Strong Buy||Strong Buy|
Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil & gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.
CEO: Theodore L. Harris
Telephone: +1 845 326-5600
Address: 52 Sunrise Park Road, New Hampton 10958, NY, US
Number of employees: 1 342
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.